For Strategic Partnering
- Susan E. Sherman, MHA, Chief Executive Officer, The LAM Foundation
Patient Advocacy groups working with NDRI provide a unique and powerful opportunity to their patient population, by allowing them to be directly involved in the science that leads to the discovery of drug therapies and answers questions of the disease mechanism. Playing an integral role in the patient’s participation in these donations can make a difference in a Patient Advocacy Group's involvement in the advancement and the discovery of finding the cause and one day a treatment or cure.
For nearly 40 years, NDRI has facilitated research and discovery through the donation of normal and diseased tissue. Patients can contribute to science by providing a “living” donation, (blood sample, urine, explanted tissue or other) or through registering to make a post-mortem gift, to leave a legacy and continue to help further scientific discoveries.
Pharmaceutical companies and researchers are increasingly working with Patient Advocacy Groups to obtain data sets, registry information, and support for drug development and identifying causes of disease. Using human tissue during drug development can help pharmaceutical companies:
NDRI's infrastructure and internal expertise in working with researchers to develop viable research protocols lead to better results. Our industry best practices in procurement, preservation, storage, and shipment of human tissues, ensure the highest quality, consistency, and reproducibility.
Whether you are an advocacy group with existing relationships to pharma and researchers, or just getting your research program up and running, NDRI can help you achieve your research goals through our many services.
Patient Advoacay Groups and Foundations we collaborate with include:
To learn more, contact us at Strategic Initiatives:
Email email@example.com or call 800-222-NDRI (6374), ext. 289